费诺纤维酸作为性结肠炎的辅助疗法:通过SIRT1,NLRP3和AMPK途径向炎症:一项随机对照试点研究
Sumaiah J Alarfaj1, Mostafa M Bahaa2, Thanaa A Elmasry3
1Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Drug design, development and therapy
|November 22, 2024
概括
费诺纤维酸,PPARα激动剂,改善了轻度至中度性结肠炎 (UC) 患者的临床结果和减少了炎症. 这表明纤维酸可能是UC治疗的有益补充.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 性结肠炎 (UC) 是结肠的慢性炎症状况.
- 过氧体增殖器激活受体α (PPARα) 激动剂在UC中表现出潜在的保护作用.
研究的目的:
- 为了评估费诺纤维酸,PPARα激动剂的疗效,作为治疗轻度至中度UC.
- 评估纤维酸对临床症状,生活质量和炎症标志物的影响.
主要方法:
- 一项随机对照试验,涉及70名患有轻度至中度UC的患者.
- 患者接受了6个月的梅萨拉与安慰剂或梅萨拉与芬诺纤维酸.
- 临床反应使用部分梅奥得分 (PMS) 和炎症性肠病问卷 (IBDQ) 进行评估.
- 测量了包括静音信息调节器1 (SIRT1),NOD类受体蛋白3 (NLRP3),腺单酸激活蛋白激酶 (AMPK) 和便calprotectin在内的生物标志物.
主要成果:
- 费诺纤维酸组显示PMS显著减少,IBDQ消化领域显著改善.
- 在 fenofibrate 组中观察到血清NLRP3 和便calprotectin 的统计显著下降.
- 费诺纤维酸组显示SIRT1和AMPK水平显著增加.
- 在接受费诺纤维酸治疗的患者中,观察到更高的临床反应和缓解率.
结论:
- 芬诺纤维酸作为轻度至中度UC的辅助疗法具有前景.
- 它可以改善临床结果和生活质量,同时调节炎症.
- 对纤维酸在UC管理中的作用进行进一步研究是有必要的.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
120
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
120
Inflammatory Bowel Disease IV: Pharmacological Management
113
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
113
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
317
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
317
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
96
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
96


